Procedural Sedation Curriculum Nationwide Children's Hospital
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Spring 2009 Student Journal
Volume 8 Number 1 Spring 2009 The International Student Journal of Nurse Anesthesia TOPICS IN THIS ISSUE MS & ECT Cardioprotection of Volatile Agents Hyperthermic Chemotherapy Intubating LMA Pierre Robin Syndrome Alpha Thalassemia Latex Allergy & Spina Bifida Distorted Upper Airway Volunteerism – Honduras INTERNATIONAL STUDENT JOURNAL OF NURSE ANESTHESIA Vol. 8 No. 1 Spring 2009 Editor - in - Chief Ronald L. Van Nest, CRNA, JD Associate Editors Vicki C. Coopmans, CRNA, PhD Julie A. Pearson, CRNA, PhD EDITORIAL BOARD & SECTION EDITORS Pediatrics Janet A. Dewan, CRNA, MS Northeastern University Obstetrics Greg Nezat, CRNA, PhD Navy Nurse Corps Anesthesia Program Research & Capstone Joseph E. Pellegrini, CRNA, University of Maryland PhD Regional / Pain Christopher Oudekerk, CRNA, Uniformed Services Universi- DNP ty of the Health Sciences Cardiovascular Michele Gold, CRNA, PhD University of Southern Cali- fornia Thoracic/ Fluid Balance Lori Ann Winner, CRNA, MSN University of Pennsylvania Unique Patient Syndromes Kathleen R. Wren, CRNA, PhD Florida Hospital College of Health Sciences Equipment Carrie C. Bowman Dalley, Georgetown University CRNA, MS Pharmacology Maria Magro, CRNA, MS, University of Pennsylvania MSN Pathophysiology JoAnn Platko, CRNA, MSN University of Scranton Special Surgical Techniques Russell Lynn, CRNA, MSN University of Pennsylvania 1 Airway & Respiration Michael Rieker, CRNA, DNP Wake Forest University Baptist Medical Center ,Nurse Anesthesia Program, Univer- sity of North Carolina at Greensboro Neurology & Neurosurgery -
Current Awareness in Clinical Toxicology Editors: Damian Ballam Msc and Allister Vale MD
Current Awareness in Clinical Toxicology Editors: Damian Ballam MSc and Allister Vale MD February 2016 CONTENTS General Toxicology 9 Metals 38 Management 21 Pesticides 41 Drugs 23 Chemical Warfare 42 Chemical Incidents & 32 Plants 43 Pollution Chemicals 33 Animals 43 CURRENT AWARENESS PAPERS OF THE MONTH How toxic is ibogaine? Litjens RPW, Brunt TM. Clin Toxicol 2016; online early: doi: 10.3109/15563650.2016.1138226: Context Ibogaine is a psychoactive indole alkaloid found in the African rainforest shrub Tabernanthe Iboga. It is unlicensed but used in the treatment of drug and alcohol addiction. However, reports of ibogaine's toxicity are cause for concern. Objectives To review ibogaine's pharmacokinetics and pharmacodynamics, mechanisms of action and reported toxicity. Methods A search of the literature available on PubMed was done, using the keywords "ibogaine" and "noribogaine". The search criteria were "mechanism of action", "pharmacokinetics", "pharmacodynamics", "neurotransmitters", "toxicology", "toxicity", "cardiac", "neurotoxic", "human data", "animal data", "addiction", "anti-addictive", "withdrawal", "death" and "fatalities". The searches identified 382 unique references, of which 156 involved human data. Further research revealed 14 detailed toxicological case reports. Current Awareness in Clinical Toxicology is produced monthly for the American Academy of Clinical Toxicology by the Birmingham Unit of the UK National Poisons Information Service, with contributions from the Cardiff, Edinburgh, and Newcastle Units. The NPIS is commissioned by Public Health England Current Awareness in Clinical Toxicology Editors: Damian Ballam MSc and Allister Vale MD February 2016 Current Awareness in Clinical Toxicology is produced monthly for the American Academy of Clinical Toxicology by the Birmingham Unit of the UK National Poisons Information Service, with contributions from the Cardiff, Edinburgh, and Newcastle Units. -
Authors Conducted an E-Mail Survey of Anesthesiologists in the US in 2010
Appendix 2: Reference 1 Methods: Authors conducted an e-mail survey of Anesthesiologists in the US in 2010. Results: “Five thousand anesthesiologists were solicited; 615 (12.3%) responses were received. Twenty-four percent of respondents had installed an AIMS, while 13% were either installing a system now or had selected one, and an additional 13% were actively searching. Larger anesthesiology groups with large case loads, urban settings, and government affiliated or academic institutions were more likely to have adopted AIMS. Initial cost was the most frequently cited AIMS barrier. The most commonly cited benefit was more accurate clinical documentation (79%), while unanticipated need for ongoing information technology support (49%) and difficult integration of AIMS with an existing EMR (61%) were the most commonly cited problems.” [Trentman TL, Mueller JT, Ruskin KJ, Noble BN, Doyle CA. Adoption of anesthesia information management systems by US anesthesiologists. J Clin Monit Comput 2011;25:129–35.] Reference 2 Joint Commission Report. 60 [Kohn L, Corrigan JM, Donaldson MS. To Err is Human: Building a Safer Health System. Report from the Committee on Quality of Health Care in America. Washington DC: The Joint Commission journal on quality improvement, 1999:227–34.] Reference 3 Excerpt: “The Department of Health and Human Services (DHHS) released two proposed regulations affecting HIT (www.healthit.hhs.gov). The first, a notice of proposed rule- making (NPRM), describes how hospitals, physicians, and other health care professionals can qualify for billions of dollars of extra Medicare and Medicaid payments through the meaningful use of electronic health records (EHRs). The second, an interim final regulation, describes the standards and certification criteria that those EHRs must meet for their users to collect the payments. -
Opioid Antagonists As Potential Therapeutics for Ischemic Stroke
Progress in Neurobiology 182 (2019) 101679 Contents lists available at ScienceDirect Progress in Neurobiology journal homepage: www.elsevier.com/locate/pneurobio Perspective article Opioid antagonists as potential therapeutics for ischemic stroke T ⁎ ⁎ Nadia Peyraviana,b, Emre Dikicia,b, Sapna Deoa,b, Michal Toboreka,b, , Sylvia Daunerta,b,c, a Department of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, USA b Dr. JT Macdonald Foundation Biomedical Nanotechnology Institute of the University of Miami, USA c University of Miami Clinical and Translational Science Institute, USA ARTICLE INFO ABSTRACT Keywords: Chronic use of prescription opioids exacerbates risk and severity of ischemic stroke. Annually, 6 million people Ischemic stroke die from stroke worldwide and there are no neuroprotective or neurorestorative agents to improve stroke out- Opioid antagonist comes and promote recovery. Prescribed opioids such as morphine have been shown to alter tight junction Blood brain barrier protein expression, resulting in the disruption of the blood brain barrier (BBB), ultimately leading to stroke Neuroprotection pathogenesis. Consequently, protection of the BBB has been proposed as a therapeutic strategy for ischemic Naloxone stroke. This perspective addresses the deficiency in stroke pharmacological options and examines a novel ap- Naltrexone plication and repurposing of FDA-approved opioid antagonists as a prospective neuroprotective therapeutic strategy to minimize BBB damage, reduce stroke severity, and promote neural recovery. Future directions discuss potential drug design and delivery methods to enhance these novel therapeutic targets. 1. Introduction modulate resulting microglia and macrophage activation in the is- chemic region to reduce neuroinflammation and prevent secondary As of 2017, the US government declared the opioid epidemic as a neurodegeneration resulting from phagocytosis of viable neurons. -
Rhomboid Intercostal Block Combined with Interscalene Nerve Block for Sternoclavicular Joint Reconstruction
CASE REPORT Ochsner Journal 21:214–216, 2021 ©2021 by the author(s); Creative Commons Attribution License (CC BY) DOI: 10.31486/toj.20.0020 Rhomboid Intercostal Block Combined With Interscalene Nerve Block for Sternoclavicular Joint Reconstruction Chihiro Toda, MD,1 Rajnish K. Gupta, MD,2 Hesham Elsharkawy, MD, MBA, MSc, FASA3 1Department of Anesthesiology and Pain Management, Cleveland Clinic, Cleveland, OH 2Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN 3MetroHealth Pain and Healing Center, Associate Professor of Anesthesiology, Case Western University, Outcome Research Consortium, Cleveland Clinic, Cleveland, OH Background: Rhomboid intercostal block is a newer technique for chest wall analgesia and can be an effective alternative to thoracic epidurals and paravertebral blocks. We performed a rhomboid intercostal block after sternoclavicular joint reconstruction surgery. Case Report: A healthy 26-year-old male who had chronic right sternoclavicular joint instability was scheduled for right medial clavicle resection with sternoclavicular joint allograft reconstruction. We performed a right interscalene single-shot nerve block fol- lowed by a rhomboid intercostal block with catheter placement under ultrasound guidance. The patient’s pain was well controlled postoperatively with minimal use of opioids. Conclusion: Rhomboid intercostal block with brachial plexus block is a potential option for analgesia after sternoclavicular joint reconstruction surgery. Keywords: Anesthesiology, fascia, nerve block, -
Evidence-Based Guidelines for the Pharmacological Management of Substance Abuse, Harmful Use, Addictio
444324 JOP0010.1177/0269881112444324Lingford-Hughes et al.Journal of Psychopharmacology 2012 BAP Guidelines BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, Journal of Psychopharmacology 0(0) 1 –54 harmful use, addiction and comorbidity: © The Author(s) 2012 Reprints and permission: sagepub.co.uk/journalsPermissions.nav recommendations from BAP DOI: 10.1177/0269881112444324 jop.sagepub.com AR Lingford-Hughes1, S Welch2, L Peters3 and DJ Nutt 1 With expert reviewers (in alphabetical order): Ball D, Buntwal N, Chick J, Crome I, Daly C, Dar K, Day E, Duka T, Finch E, Law F, Marshall EJ, Munafo M, Myles J, Porter S, Raistrick D, Reed LJ, Reid A, Sell L, Sinclair J, Tyrer P, West R, Williams T, Winstock A Abstract The British Association for Psychopharmacology guidelines for the treatment of substance abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on their pharmacological management. They are based explicitly on the available evidence and presented as recommendations to aid clinical decision making for practitioners alongside a detailed review of the evidence. A consensus meeting, involving experts in the treatment of these disorders, reviewed key areas and considered the strength of the evidence and clinical implications. The guidelines were drawn up after feedback from participants. The guidelines primarily cover the pharmacological management of withdrawal, short- and long-term substitution, maintenance of abstinence and prevention of complications, where appropriate, for substance abuse or harmful use or addiction as well management in pregnancy, comorbidity with psychiatric disorders and in younger and older people. Keywords Substance misuse, addiction, guidelines, pharmacotherapy, comorbidity Introduction guidelines (e.g. -
Northwest Arkansas Regional Ems Protocols
Regional Protocol PROTOCOL SECTION NORTHWEST ARKANSAS REGIONAL EMS PROTOCOLS 2019 REVISION 2019 a Regional Protocol PROTOCOL SECTION TABLE OF CONTENTS……………………………………………………………………………….b - e INTRODUCTORY STATEMENT………………......……………………………………………….........f PARTICIPATING AGENCIES………………………………………………………………………….…………..g 2019 DEPARTMENT MEDICAL DIRECTORS & SIGNATURE………………..…………………………........h SECTION ONE - PROTOCOLS GENERAL PROTOCOLS UNIVERSAL PATIENT CARE ................................................................................................................... 1 CHEMICAL EXPOSURE (HAZMAT) ......................................................................................................... 2 CHEMICAL SEDATION FOR VIOLENT PATIENT .................................................................................... 3 PAIN MANAGEMENT ............................................................................................................................... 4 SPINAL RESTRICTION ............................................................................................................................ 5 VASCULAR ACCESS ............................................................................................................................... 6 RESPIRATORY OXYGEN ADMINISTRATION……….…………………………………………………………..…………………..7 GENERAL AIRWAY MANAGEMENT………………….……………………………………..…………………….8 ADVANCED AIRWAY MANAGEMENT….……………………………………………………..…………………..9 PHARMACOLOGICAL ASSISTED INTUBATION (PAI)………………….……………………………………..10 ALLERGIC REACTION—ANAPHYLAXIS….……………………………………………………………………..11 -
The Use of Remifentanil As the Primary Agent for Analgesia in Parturients
The Use Of Remifentanil As The Primary Agent For Analgesia In Parturients Author: Bryan Clifford Anderson, DNAP, CRNA Learning Objectives for this Self Study: The Importance of Exploring Remifentanil as an Upon completion of this study, the CRNA will be able to: Option for Treating Labor Pain The use of remifentanil in the parturient as the primary analgesic is 1. Discuss the significance of remifentanil use as a primary analgesic significant for several reasons; the most salient of which is the basic human agent in parturients for whom neuraxial anesthesia is not an option. right to the management of pain. Pain, as defined by the International Association for the Study of Pain (IASP), is “an unpleasant sensory and 2. Identify clients in which neuraxial anesthesia might be contraindicated. emotional experience associated with actual or potential tissue damage.” 2 Labor is a cause of severe pain for many women and is a problem that should 3. Compare the efficacy of select medications in the control of pain be addressed and managed in accordance with the needs and wishes of the in paturients. individual patient. Interventions that alleviate or eliminate pain are not merely a matter of beneficence, but also form part of the duty to prevent harm.3 4. Appraise findings in current evidence to determine to what extent The variations in pain perception among women in labor creates an essential remifentamil is a viable option for pain management in parturient patients. component in the administration of anesthesia in the provision of patient- centered anesthesia care. One recent study identifies that the perception of 5. -
A Comparison of Wilson Risk Sum Score and Combination of Modified Mallampati Classification, Hyomental Distance Ratio, Ratio Of
Jebmh.com Original Research Article A Comparison of Wilson Risk Sum Score and Combination of Modified Mallampati Classification, Hyomental Distance Ratio, Ratio of Height to Sternomental and Thyromental Distances for Predicting Difficult Laryngoscopy in Indian Population Deepak Kumar1, Saurabh Bhargava2, Ravindra Singh Sisodiya3, Deepak Tiwari4 1Department of Anaesthesia, National Institute of Medical Sciences and Research Centre, Jaipur, Rajasthan, India. 2, 4 Department of Emergency Medicine, National Institute of Medical Sciences and Research Centre, Jaipur, Rajasthan, India. 3Department of Anaesthesia, Mahatma Gandhi Medical College and Hospital, Jaipur, Rajasthan, India. ABSTRACT BACKGROUND A few patients of apparently normal appearance unexpectedly present with great Corresponding Author: difficulties during intubation which may lead to potentially serious consequences. Dr. Deepak Tiwari, Thus, we worked on this area with the aim to determine the ability to predict 109 Avar Faculty Block, Nims University, Shobha Nagar, difficult visualisation of larynx using the following preoperative airway predictors: Delhi-Jaipur Highway, MMC (Modified Mallampati Classification), RHSMD (Ratio of Height to Sternomental Jaipur - 302013, Distance), RHTMD (Ratio of Height to Thyromental) and HMDR (Hyomental Rajasthan, India. Distance Ratio) and comparison of these with WRSS (Wilson Risk Sum Score), in E-mail: [email protected] isolation and in combination. DOI: 10.18410/jebmh/2020/620 METHODS A double-blind, prospective study was carried out on 300, ASA grade I or II How to Cite This Article: patients posted for elective surgery in supine position under general anaesthesia. Kumar D, Bhargava S, Sisodiya RS, et al. A comparison of Wilson risk sum score Different parameters were recorded in pre-op period and Cormack-Lehane grading and combination of modified Mallampati and difficulty of intubation was recorded at the time of intubation. -
Clinical Policy: Nerve Blocks for Pain Management Reference Number: CP.MP.170 Coding Implications Last Review Date: 08/20 Revision Log
Clinical Policy: Nerve Blocks for Pain Management Reference Number: CP.MP.170 Coding Implications Last Review Date: 08/20 Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description Nerve blocks are the temporary interruption of conduction of impulses in peripheral nerves or nerve trunks created by the injection of local anesthetic solutions. They can be used to identify the source of pain or to treat pain. Note: For sacroiliac nerve block and radiofrequency neurotomy, please refer to CP.MP.166 Sacroiliac Joint Interventions Policy/Criteria It is the policy of health plans affiliated with Centene Corporation® that invasive pain management procedures performed by a physician are medically necessary when the relevant criteria are met and the patient receives only one procedure per visit, with or without radiographic guidance. Table of Contents I. Occipital Nerve Block............................................................................................................. 1 II. Sympathetic Nerve Blocks ...................................................................................................... 2 III. Celiac Plexus Nerve Block/Neurolysis ................................................................................... 3 IV. Intercostal Nerve Block/Neurolysis ........................................................................................ 3 V. Genicular Nerve Blocks and Genicular Nerve Radiofrequency Neurotomy .......................... 3 VI. Peripheral nerve -
Thyromental Distance Ratio in Predicting Difficult Intubation
THE EFFECTIVENESS OF EXTENDED MALLAMPATI TEST, HYOMENTAL DISTANCE RATIO AND NECK CIRCUMFERENCE – THYROMENTAL DISTANCE RATIO IN PREDICTING DIFFICULT INTUBATION BY EZIKE AMECHI CHUKWUDUM DEPARTMENT OF ANAESTHESIA UNIVERSITY OF CALABAR TEACHING HOSPITAL CALABAR, NIGERIA A DISSERTATION SUBMITTED TO NATIONAL POSTGRADUATE MEDICAL COLLEGE OF NIGERIA IN PARTIAL FULFILLMENT OF THE FINAL FELLOWSHIP OF THE MEDICAL COLLEGE IN ANAESTHESIA (FMCA) EXAMINATION REQUIREMENT MAY 2017 1 SUPERVISORS ATTESTATION We hereby affirm that we supervised this study carried out by Dr. Amechi Chukwudum Ezike titled EFFECTIVENESS OF EXTENDED MALLAMPATI SCORE, HYOMENTAL DISTANCE RATIO AND NECK CIRCUMFERENCE- THYROMENTAL DISTANCE RATIO IN PREDICTING DIFFICULT INTUBATION , in partial fulfillment for the requirement of the award of the Fellowship of the National Postgraduate Medical College of Nigeria. First Supervisor……………………………………………… Date…………………………….. Prof. Atim I. Eshiet (MBBCh, DA, FMCA, FICS, FWACS) Consultant Anaesthetist, University of Calabar Teaching Hospital, Calabar, Nigeria. Second Supervisor …………………………………… Date……………………………… DR. Iniabasi Udoh Ilori (MBBCh; DA; FWACS). Consultant Anaesthetist, University of Calabar Teaching Hospital, Calabar, Nigeria. 2 CERTIFICATION I affirm that this dissertation titled ‘Effectiveness Of Extended Mallampati Score, Hyomental Distance Ratio And Neck Circumference-Thyromental Distance Ratio In Predicting Difficult Intubation’ was carried out by Dr. Ezike Amechi Chukwudum and supervised by consultants in the Department of Anaesthesiology, University of Calabar Teaching Hospital. This is in partial fulfillment of the requirement for the award of the Fellowship of the National Postgraduate Medical College of Nigeria. …………………………………………… Date………………………. DR. OBOKO OKU (MBBCh; DA; FWACS). The Head, Department of Anaesthesiology, University of Calabar Teaching Hospital (UCTH), Calabar, Nigeria. 3 DECLARATION I hereby declare that this work is original unless otherwise stated. -
Quadazocine Decreases Responding Reinforced by Ethanol, Sucrose, and Phencyclidine Fluid Deliveries in Rhesus Monkeys: Comparison to Naltrexone’S Effects
Psychopharmacology (1999) 144:316–322 © Springer-Verlag 1999 ORIGINAL INVESTIGATION Keith L. Williams · Eric D. Pakarinen James H. Woods Quadazocine decreases responding reinforced by ethanol, sucrose, and phencyclidine fluid deliveries in rhesus monkeys: comparison to naltrexone’s effects Received: 24 June 1998 / Accepted: 18 February 1999 Abstract Rationale: The endogenous opioid system experiments, and thus we cannot rule out rate-dependent may mediate the reinforcing effects of ethanol as well as effects of the antagonists. sweet-tasting solutions. For example, opioid antagonists, such as naltrexone, reduce ethanol- and sucrose-rein- Key words Opioid antagonists · Alcohol reinforcement · forced responding in rhesus monkeys. If these effects are Self-administration · Primates due to blockade of the µ-receptor, then an opioid antago- nist such as quadazocine with a receptor selectivity pro- file similar to that of naltrexone should reduce respond- Introduction ing at doses correlated with its µ-selectivity. Objectives: To determine whether quadazocine would reduce re- The endogenous opioid system modulates alcohol drink- sponding for ethanol and sucrose at µ-selective doses, ing. In preclinical and clinical studies, opioid antagonists and whether quadazocine and naltrexone would reduce reduce alcohol drinking. For instance, we have previous- responding for a bitter-tasting drug solution such as ly shown that naltrexone (NTX) pretreatment in rhesus phencyclidine. Methods: Rhesus monkeys were given monkeys reduced oral ethanol self-administration access to ethanol, sucrose, or phencyclidine concurrently (Williams et al. 1998). In other studies using many dif- with water. Prior to the drinking sessions, quadazocine ferent animal species, NTX and other opioid antagonists (0.032–3.2 mg/kg) or saline was injected intramuscular- reduced oral ethanol self-administration (Levine and ly.